Autism in adults

Developmental formulation #

Autism combines persistent social-communication differences with restricted or repetitive patterns and sensory differences, with developmental onset and functional consequences. Adult recognition can occur after years of adaptation. Describe strengths and support needs rather than treating the diagnosis as a uniform severity category.

Adult assessment #

Explore childhood relationships, routines, communication, focused interests and sensory experiences. Seek developmental collateral when available and acceptable. Examine current adaptive skills and the cost of coping with everyday demands; distinguish communication style from thought disorder.

Coexisting conditions and overlap #

Indication-based investigation #

Autism is diagnosed clinically through developmental and behavioural assessment. Testing addresses suspected coexisting conditions: hearing concerns need hearing assessment; neurological or medical findings require their own evaluation. A laboratory result is not a substitute for the developmental history.

Intervention targets #

Agree goals that matter to the person: accessible communication, participation, relationships, work and daily living. Reduce sensory and communication barriers and coordinate support with education, employment and social services. Explain adaptations concretely and allow processing time.

For behaviour that challenges, use functional analysis and psychosocial/environmental interventions. Medicines are for a defined coexisting disorder or a specialist, time-limited behavioural indication—not for making the person appear less autistic.

Doses & prescribing #

Each prescribing record identifies its population and source jurisdiction; international labeling does not establish Indian approval. The clinician selects treatment after assessment.

This presentation does not have a routine diagnosis-based drug regimen. Indication-specific prescribing and its limitations are described in the treatment section.

When an intervention is ineffective #

Check whether the intervention matches the person’s communication and sensory needs. For specialist antipsychotic treatment of behaviour that challenges, NICE recommends review after 3–4 weeks and stopping if there is no clinically important response by 6 weeks. This is an off-label adult indication in that guideline, not a routine regimen.

Longitudinal support #

Support needs can change with work demands, housing, health and relationships. Keep goals under review and arrange continuity during service transitions. Include family or carers according to the person’s preferences and communication needs.

Adapt treatment to the person #

Intellectual ability varies widely and does not by itself define independence. Use accessible explanations and distinguish a communication barrier from inability to participate in decisions. Treat anxiety, depression and other comorbidities using disorder-specific care adapted to the autistic person.

Outcomes to monitor #

Record a concrete target before intervention, then review distress, participation, daily function and quality of life. If medicine is used, review its defined target and adverse effects alongside psychosocial care; behavioural suppression alone is not an adequate outcome.

Avoid unsupported treatment #

Do not prescribe antipsychotics, antidepressants or anticonvulsants for core adult autistic features. Avoid chelation, unindicated exclusion diets and supplements promoted as autism treatments. No generic dose table is appropriate for core autism; select the relevant comorbid-condition chapter when prescribing.

Assessment tools #

Choose the instrument for its intended purpose; interpretation accompanies the linked tool.

Patient discussion #